Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS)

38 filings reported holding PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share as of Q4 2022.
Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 19,762,209 shares of 62,933,385 outstanding shares and own 31% of the company stock.
Largest 10 shareholders include TANG CAPITAL MANAGEMENT LLC (3,470,700 shares), Laurion Capital Management LP (3,170,803 shares), BVF INC/IL (2,938,851 shares), CITADEL ADVISORS LLC (1,562,798 shares), Newtyn Management, LLC (1,500,000 shares), BARCLAYS PLC (948,051 shares), VANGUARD GROUP INC (917,827 shares), ORBIMED ADVISORS LLC (848,252 shares), HHLR ADVISORS, LTD. (764,406 shares), and Tekla Capital Management LLC (708,303 shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.